TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Cannabis Stocks
Why Canopy Growth Stock Plunged 66% in 2021

Investing
Is BlackBerry (TSX:BB) Stock or Canopy Growth (TSX:WEED) Stock a Buy in January?

Cannabis Stocks
Why Canopy Growth Stock Fell 20% in December

Cannabis Stocks
These 5 Cannabis Stocks Are High-Risk Holdings Like Bitcoin

Investing
2 Unloved 2021 Stocks That Could Soar in 2022

Cannabis Stocks
Why Is Canopy Growth Stock up 8% in the Last Week?

Investing
Late Christmas Gift: Why Stocks Could Soar in January

Investing
Down Over 10% in December: Should You Buy These 3 Canadian Stocks?

Cannabis Stocks
2 Dirt-Cheap Cannabis Stocks That Could Soar in 2022

Investing
4 High-Growth TSX Stocks That Dropped on Monday: Should You Buy?

Cannabis Stocks
Canopy Growth (TSX:WEED) Falls 11% and Hits 52-Week Low
